These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Degiuli M; Sasako M; Ponti A; Calvo F Br J Cancer; 2004 May; 90(9):1727-32. PubMed ID: 15150592 [TBL] [Abstract][Full Text] [Related]
10. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463 [TBL] [Abstract][Full Text] [Related]
11. Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma. Staerkle RF; Vuille-Dit-Bille RN; Soll C; Troller R; Samra J; Puhan MA; Breitenstein S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011490. PubMed ID: 33471373 [TBL] [Abstract][Full Text] [Related]
12. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. Degiuli M; Reddavid R; Tomatis M; Ponti A; Morino M; Sasako M; Eur J Cancer; 2021 Jun; 150():10-22. PubMed ID: 33887514 [TBL] [Abstract][Full Text] [Related]
13. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile? Yildirim E; Celen O; Berberoglu U J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920 [TBL] [Abstract][Full Text] [Related]
14. Resection for gastric cancer in the community. van de Velde CJ Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441 [TBL] [Abstract][Full Text] [Related]
15. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772 [TBL] [Abstract][Full Text] [Related]
16. Mortality and Morbidity and Disease Free Survival after D1 and D2 Gastrectomy for Stomach Adenocarcinomas. Talaiezadeh AH; Asgari M; Zargar MA Asian Pac J Cancer Prev; 2015; 16(13):5253-6. PubMed ID: 26225661 [TBL] [Abstract][Full Text] [Related]
17. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial. Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843 [TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M; Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296 [TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer. Jiang L; Yang KH; Chen Y; Guan QL; Zhao P; Tian JH; Wang Q Br J Surg; 2014 May; 101(6):595-604. PubMed ID: 24668465 [TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]